Epoqe Pharma ApS
Private limited companyCVR 42443670FrederiksbergActive
Epoqe Pharma ApS is a private limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2021. The company made a loss in both 2024 and 2025, most recently DKK 13.9m. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 1,178% (2024 → 2025), to −DKK 13.7m.
- The loss grew: from DKK 136k to DKK 13.9m (2024 → 2025).
- Equity turned positive again: DKK 30m (2024 → 2025).
Employees
- 2 more employees than a year earlier: 5 (07/2026) against 3 (07/2025).
Management and owners, last 24 months
- New in management: Anders Gaarsdal Holst (chair of the board, 09/01/2025), Henrijette Elsebeth Richter (board member, 09/01/2025) and Lars Gredsted (board member, 09/01/2025) (+2).
- Stepped down: Anette Sams Nielsen (ceo, 02/06/2026), Jens Thostrup Bukrinski (director, 31/07/2025) and Anders Gaarsdal Holst (board member, 08/01/2025) (+2).
- New owners registered: Lundbeckfond Invest A/S (28/08/2026), Helms & Sams ApS (28/08/2026) and CMCGreenhouse ApS (28/08/2026) (+5).
- No longer registered as owner: Helms & Sams ApS (20/11/2025), CMCGreenhouse ApS (20/11/2025) and Sofinnova Capital X (20/11/2025) (+4).
Registrations, last 24 months
- 28/08/2026: Share capital changed from 288,886 DKK to 399,997 DKK
- 21/11/2025: Share capital changed from 219,998 DKK to 288,886 DKK
- 09/01/2025: Share capital changed from 175,554 DKK to 219,998 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2022–2025 · amounts in DKK thousandEquity and net profit
| 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | – |
| Gross profit | −17 | −19 | 1,273 | −13,720 | −1,177.6% |
| Operating profit (EBIT) | −17 | −19 | −173 | −16,893 | −9,676.6% |
| Profit before tax | −18 | −20 | −174 | −16,695 | −9,480.6% |
| Net profit | −18 | −15 | −136 | −13,944 | −10,159% |
| Total assets | 145 | 2,580 | 1,111 | 34,851 | +3,036.7% |
| Equity | 133 | 118 | −18 | 30,042 | +164,561.4% |
| Liabilities | 12 | 2,462 | 1,129 | 4,808 | +325.8% |
| Cash and cash equivalents | 145 | 2,559 | 988 | 30,227 | +2,960.1% |
| Average number of employees | – | – | 2 | 3 | +50% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 4 years in a row
Net result has been negative in 2022–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
4 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/07/2024 – 30/06/2025 | 10/03/2026 | The company | PDF not statedXBRL |
| 2024 | 01/07/2023 – 30/06/2024 | 17/07/2024 | The company | PDFXBRL |
| 2023 | 01/07/2022 – 30/06/2023 | 17/10/2023 | The company | PDFXBRL |
| 2022 | 04/06/2021 – 30/06/2022 | 28/10/2022 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,676of 69,742 Better than 0% | No. 4,473of 69,964 Better than 94% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 314of 323 Better than 3% | No. 26of 329 Better than 92% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 33,531of 33,588 Better than 0% | No. 1,736of 33,687 Better than 95% |
| All companies of type ApS66,508 companies in the comparison | No. 66,314of 66,379 Better than 0% | No. 3,168of 66,505 Better than 95% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Epoqe Pharma ApS−DKK 13.7m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Epoqe Pharma ApS−DKK 13.9m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Epoqe Pharma ApSDKK 30m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Epoqe Pharma ApS5
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Edvince ApS5%
- Lundbeckfond Invest A/S33.33%
- Helms & Sams ApS5%
- CMCGreenhouse ApS5%
- Sofinnova Capital X33.33%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Mark Stephen Sumeray | CEO | 02/06/2026 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Anders Gaarsdal Holst | Chair of the board | 09/01/2025 |
| Henrijette Elsebeth Richter | Board member | 09/01/2025 |
| Lars Gredsted | Board member | 09/01/2025 |
| Mark Stephen Sumeray | Board member | 22/06/2026 |
- Founders
- Helms & Sams ApS, Edvince ApS
Former management (8)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Anette Sams Nielsen | Director | 04/06/2021 | 13/12/2021 |
| Anette Sams Nielsen | CEO | 14/12/2021 | 02/06/2026 |
| Jens Thostrup Bukrinski | Director | 14/12/2021 | 31/07/2025 |
| Anders Gaarsdal Holst | Board member | 12/10/2023 | 08/01/2025 |
| Jan Bjerrum Bach | Chair of the board | 12/10/2023 | 19/09/2024 |
| Alejandra Maria Cristina Bonifacini Mørk | Board member | 12/10/2023 | 19/09/2024 |
| Henrijette Elsebeth Richter | Chair of the board | 19/09/2024 | 08/01/2025 |
| Anette Sams Nielsen | Board member | 19/09/2024 | 22/06/2026 |
Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Address and production units
1 active production unitsNordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (8)
- Sparrow Quantum ApSManufacture of computers and peripheral equipment
- Adcendo ApSResearch and experimental development on natural sciences and engineering
- Hemab ApSManufacture of pharmaceutical preparations
- Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
- Minervax ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Epoqe Pharma ApS | Nordre Fasanvej 215, 2000 Frederiksberg | 5 | 1027233534 |
Purpose
Selskabets formål er at udvikle og markedsføre et eller flere lægemidler, herunder at drive forskning med henblik på at identificere, validere, udvikle og markedsføre lægemidler tillige med anden virksomhed, der står i forbindelse hermed.
The purpose is quoted from the register in Danish.
Changes year by year
73 registered events202614 changescapital 1 · ownership 8 · management 4 · accounts 1
- CapitalShare capital changed from 288,886 DKK to 399,997 DKK
- OwnershipLUNDBECKFOND INVEST A/S registered as owner (33.33%)
- OwnershipSofinnova Capital X registered as owner (33.33%)
- OwnershipCMCGreenhouse ApS registered as owner (5%)
- OwnershipHelms & Sams ApS registered as owner (5%)
- OwnershipHelms & Sams ApS is no longer registered as owner
- OwnershipSofinnova Capital X is no longer registered as owner
- OwnershipCMCGreenhouse ApS is no longer registered as owner
- OwnershipLUNDBECKFOND INVEST A/S is no longer registered as owner
- ManagementMark Stephen Sumeray appointed board member
- ManagementAnette Sams Nielsen stepped down as board member
- ManagementMark Stephen Sumeray appointed ceo
- ManagementAnette Sams Nielsen stepped down as ceo
- AccountsAnnual report for 2025 published
202516 changescapital 2 · ownership 7 · management 6 · industry 1
- CapitalShare capital changed from 219,998 DKK to 288,886 DKK
- OwnershipHelms & Sams ApS registered as owner (10%)
- OwnershipSofinnova Capital X registered as owner (33.33%)
- OwnershipCMCGreenhouse ApS registered as owner (5%)
- OwnershipCMCGreenhouse ApS is no longer registered as owner
- OwnershipHelms & Sams ApS is no longer registered as owner
- OwnershipSofinnova Capital X is no longer registered as owner
- ManagementJens Thostrup Bukrinski stepped down as director
- CapitalShare capital changed from 175,554 DKK to 219,998 DKK
- ManagementAnders Gaarsdal Holst appointed chair of the board
- ManagementLars Gredsted appointed board member
- ManagementHenrijette Elsebeth Richter appointed board member
- OwnershipLUNDBECKFOND INVEST A/S registered as owner (20%)
- ManagementHenrijette Elsebeth Richter stepped down as chair of the board
- ManagementAnders Gaarsdal Holst stepped down as board member
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202415 changescapital 1 · management 4 · ownership 8 · accounts 1 · address 1
- CapitalShare capital changed from 88,888 DKK to 175,554 DKK
- ManagementHenrijette Elsebeth Richter appointed chair of the board
- ManagementAnette Sams Nielsen appointed board member
- ManagementAlejandra Maria Cristina Bonifacini Mørk stepped down as board member
- ManagementJan Bjerrum Bach stepped down as chair of the board
- OwnershipCMCGreenhouse ApS registered as owner (10%)
- OwnershipHelms & Sams ApS registered as owner (15%)
- OwnershipSofinnova Capital X registered as owner (33.33%)
- OwnershipEdvince ApS registered as owner (5%)
- OwnershipThomsen Pharma ApS is no longer registered as owner
- OwnershipHelms & Sams ApS is no longer registered as owner
- OwnershipEdvince ApS is no longer registered as owner
- OwnershipCMCGreenhouse ApS is no longer registered as owner
- AccountsAnnual report for 2024 published
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
20234 changesaccounts 1 · management 3
- AccountsAnnual report for 2023 published
- ManagementAlejandra Maria Cristina Bonifacini Mørk appointed board member
- ManagementJan Bjerrum Bach appointed chair of the board
- ManagementAnders Gaarsdal Holst appointed board member
20223 changesaccounts 1 · ownership 2
- AccountsAnnual report for 2022 published
- OwnershipHelms & Sams ApS registered as owner (33.33%)
- OwnershipBiologik ApS is no longer registered as owner
202121 changescapital 2 · ownership 12 · name 1 · address 1 · management 4 · founded 1
- CapitalShare capital changed from 57,777 DKK to 88,888 DKK
- OwnershipEdvince ApS registered as owner (20%)
- OwnershipCMCGreenhouse ApS registered as owner (25%)
- OwnershipThomsen Pharma ApS registered as owner (5%)
- OwnershipBiologik ApS registered as owner (33.33%)
- NameName changed from Patentselskabet af 31. maj 2021 ApS. to Epoqe Pharma ApS
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
- CapitalShare capital changed from 40,000 DKK to 57,777 DKK
- ManagementAnette Sams Nielsen appointed ceo
- ManagementJens Thostrup Bukrinski appointed director
- OwnershipEdvince ApS registered as owner (33.33%)
- OwnershipEdvince ApS is no longer registered as owner
- OwnershipBiologik ApS is no longer registered as owner
- ManagementAnette Sams Nielsen stepped down as director
- OwnershipEdvince ApS is no longer registered as owner
- OwnershipBiologik ApS registered as owner (50%)
- OwnershipHelms & Sams ApS is no longer registered as owner
- FoundedRegistered as Patentselskabet af 31. maj 2021 ApS.
- ManagementAnette Sams Nielsen appointed director
- OwnershipHelms & Sams ApS registered as owner (50%)
- OwnershipEdvince ApS registered as owner (50%)
Related companies
Same industry in Frederiksberg
- Adcendo ApS49 employees
- Orbis Medicines ApS32 employees
- Minervax ApS28 employees
- Inprother ApS18 employees
- Acesion Pharma ApS16 employees
- Kost Studio ApS11 employees
Same people in management
- Phillips-Medisize A/Svia Alejandra Maria Cristina Bonifacini Mørk
- Klifo A/Svia Alejandra Maria Cristina Bonifacini Mørk
- Takeda Pharma A/Svia Alejandra Maria Cristina Bonifacini Mørk
- Mindway AI ApSvia Jan Bjerrum Bach
- Freya Biosciences ApSvia Henrijette Elsebeth Richter
- Muna Therapeutics ApSvia Henrijette Elsebeth Richter
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.